Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis

Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis

Abstract Background Preoperative treatment of anti-vascular endothelial growth factor (VEGF) agents is extensively used in proliferative diabetic retinopathy (PDR), but the molecular mechanism is not fully understood. The objective of this research is to observe change of protein profile induced by...

Full description

Bibliographic Details
Main Authors: Chen Zou, Changjing Han, Minjie Zhao, Jingjing Yu, Lin Bai, Yuan Yao, Shuaixin Gao, Hui Cao, Zhi Zheng
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Clinical Proteomics
Subjects:
Proteomics
Proliferative diabetic retinopathy
Ranibizumab
Online Access:http://link.springer.com/article/10.1186/s12014-018-9187-z

Internet

http://link.springer.com/article/10.1186/s12014-018-9187-z

Similar Items